human papilloma virus related endocervical adenocarcinoma
about
sameAs
HEp-2KBHO-8910PMHO-8910PC-931-5c-411-425634-11ACC-2ACC-3ACC-MACr41ACr42ADLC-5M2AKIAOAV3BCaP-37BCC-1/KMCBEL-7402BEL-7402/5-FUBEL-7402/5'-DFURBEL-7404BEL-7404-CP.3BEL-7404-CP1BEL-7404-CP20BEL-7404-CP7.5BGC-823BrCA 5BT-BC16CAC-1CaOVCaVeCellSensor ESRE-bla HeLaCellSensor HSE-bla HeLaCellSensor MMTV-bla HeLaCellSensor T-REx FOXO3-DBE-bla HeLaCellSensor T-REx NICD-CSL-bla HeLa
P5166
Monitoring the HPV vaccination program in The NetherlandsCisplatin or ImmunoTHerapy in Association With Definitive Radiotherapy in HPV-related oropharyngEal Squamous Cell Carcinoma: a Randomized Phase II Trial.Treatment of Oral Warts in HIV+ PatientsTolerability, Safety, & Efficacy of Argon Plasma Coagulation to Treat Anal Intraepithelial Neoplasia in HIV-Positive MenA Study of Cisplatin Plus Radiotherapy Compared to Cetuximab Plus Radiotherapy in Locally Advanced Head and Neck Cancer.Gardasil Vaccination as Therapy in Low Grade Cervical AbnormalitiesHuman Papilloma Virus Vaccination in Girls With Cystic Fibrosis (VACCIN-HPV-MUC2)Quantitative HPV Genotyping in Screening of Anal Intraepithelial Neoplasia in HIV-positive PatientsPhase 3 Study of Imiquimod Creams in the Treatment of External Genital WartsDe-intensification of Radiation & Chemotherapy in Low-Risk Human Papillomavirus-related Oropharyngeal Squamous Cell CaCommunity Awareness, Resources and Education (CARE II): Project 3Development of Thermoablation DeviceA Study of Safety and Primary Immunogenicity of 9-valent HPV Recombinant VaccineIncreasing Human Papillomavirus (HPV) Vaccine Uptake Via General Health MessagingInfrared Bioeffect System for the Treatment of Cutaneous Warts
P921
Q16554737-1d4d26aa-48f1-8edd-f327-b221f156645aQ28334825-5f24a896-446f-25eb-72a1-67672cb42e27Q38151257-BE25A43F-F9F4-4B7A-844C-3DD707A0473DQ38151529-E0239DF7-049D-4A28-B753-947017B3C67BQ54086637-F71BC73D-4BCF-4F42-ADD8-63B94515BC23Q54399838-6CA287DC-24C4-408C-918C-E0E0A57ED81EQ54399881-37342A2C-D0CB-40A5-A04A-2BF15625F6E2Q54583662-19B9A3FD-3DE1-4982-A508-795E6522859FQ54602840-366019B8-4D6F-4983-BAE3-D58AB31EEA1CQ54608098-CE64C148-C576-459F-9114-7896CE8F0C3FQ54608099-BE6DF4E4-EE0A-4575-9470-519D77312914Q54608240-9CC8875C-F8BC-4D3F-A051-F9A41584D34DQ54608546-0FA7EAB0-34D0-406B-940E-DB16DA9F8EB3Q54608547-ABC50A55-F548-4EC4-B851-C0078CC2E41DQ54608860-C5AA4137-8692-4D63-ABB5-1043E3139FB9Q54749095-7FC873AE-152B-422C-8635-2BA8FBE831E3Q54750101-C8A510DD-DF11-4FD1-9F78-4091136B7627Q54751895-1478037F-F066-4ECA-A2CA-AAF5F80C5D3AQ54795332-E036F683-ED24-421D-9FBC-FEAB9F5AAFF9Q54795337-ED3B3336-5484-464B-89ED-6F9CDD76D4E4Q54795968-4AB31842-F9CD-49EB-ADD0-518E2C450173Q54795970-EB964D77-70C2-4BA8-9749-2521EEA47B6BQ54795971-71E6D25E-79C2-4F92-9736-29363ECFA3F3Q54795973-395A1369-6780-4D86-B0FC-4DFCBE592478Q54795975-7B549A4C-A9D5-467C-B3D0-B7A21D4AFC15Q54795978-781680BB-3DCF-4F7E-B9A4-EFA213A2289DQ54795979-9D20ED33-20C1-42C4-B708-74B62C69F7F8Q54795982-C53FBE1A-39F6-4DB1-9E72-6CE364BE3166Q54796238-FF7184B0-23BE-4F5B-9D02-5467A5F33D69Q54798201-0D9AB5DA-D568-48D8-87F4-3B565B59F674Q54798477-51FAA1B9-33C0-43AB-838B-14472BE3F930Q54807864-89E967F2-FF41-4D1F-BE28-BFADE6411CF0Q54808310-1DF2072F-3FD2-44FA-A9A1-BBEF5E43104FQ54808581-908992E5-DE70-42D4-BEFF-DCC382D647B3Q54808631-B675E925-6C9B-4204-9C3A-569DE36A310BQ54809179-7C4D41A2-1BBC-40CE-BC55-DB7335A7C3B3Q54809186-53C42602-7EF8-40DE-88C0-DC0BA382467CQ54809200-F7B104A4-F6ED-47D9-A1A6-FC01067C2CC6Q54809237-536A7631-C42A-490E-878D-614C67526B6AQ54809239-693C3E84-6C41-4BEB-BE43-26658133C27B
P5166
Q56459566-e2f667ea-4c23-54c5-b0bc-2c30c517b8a2Q61902373-007AE9C5-BDA6-4B36-A546-5D669DEB747FQ61920736-5E81B058-9F5E-4FF7-81F7-609D33FF069CQ61921289-09F7FE01-02CA-42FE-B933-ED443F13F39BQ61975400-895198F6-3ED4-413C-A8D9-666E8BAE64A7Q61980359-868680BF-4B33-4BC4-B457-78FE32541AFFQ62025167-1372F767-B952-49F8-B0C5-60610FA49DC9Q62034759-730764FE-EC28-40A2-9BCE-EB8D434BAC9DQ63063445-9D47591D-7751-4FE7-BA18-BAA045FD1D25Q63316896-BA7DE8F3-2EBE-492F-AC40-3FDFC49AF686Q63338385-FE7221ED-9420-4F99-9D45-6A0ED2FFCC4AQ63404504-29D51024-1DA9-4071-8D0D-37BC8193FCF1Q63578903-D5B1A643-A3EF-4376-AF4B-C68781FEDC84Q63592637-FD98DA58-2B9D-40CB-B3ED-4FF5846B0F6CQ63596495-5C3DAF9A-7AC3-40AE-9F3D-7C00D0E6D701
P921
human papilloma virus related endocervical adenocarcinoma
description
Human disease
@en
مرض يصيب الإنسان
@ar
name
HPV-relatert endocervikalt adenokarsinom
@nn
human papilloma virus related endocervical adenocarcinoma
@en
type
label
HPV-relatert endocervikalt adenokarsinom
@nn
human papilloma virus related endocervical adenocarcinoma
@en
altLabel
HPV-Related Endocervical adenocarcinoma
@en
HPV-related endocervical adenocarcinoma
@en
prefLabel
HPV-relatert endocervikalt adenokarsinom
@nn
human papilloma virus related endocervical adenocarcinoma
@en